Testing LY4065967 for chronic knee osteoarthritis pain
Treatments studied
Part of Bones, joints & muscles, Pain clinical trials.
This study tests an experimental drug called LY4065967 to see if it can help reduce pain from osteoarthritis in the knee. You'll be in the trial for several months, with regular check-ins and pain assessments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Knee pain that has lasted more than 12 weeks
- X-ray confirmation of osteoarthritis (moderate to severe, grades 2–4)
- Body mass index of 40 or less
- Blood sugar control that is stable (HbA1c ≤10)
- No knee surgery or injections in the past 3 months
- No artificial joints or hardware in the affected knee
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication called LY4065967 can reduce chronic low back pain. Researchers want to see if it works better than current treatments for people who have had lower back pain for at least 3 months.
This study tests new treatments for chronic pain that lasts at least 3 months. Participants must stop their regular pain medicines and use only a rescue painkiller if needed. The goal is to find better ways to manage long-term pain.
This trial studies ICM-203, a new treatment, to see if it is safe and if it can help symptoms in people with knee osteoarthritis. It mainly looks at safety and early signs of benefit for knee pain and function.
This study tests a personalized approach to managing knee osteoarthritis pain by engaging the brain's natural pain-control systems. It aims to find the best way to reduce pain for each person, potentially offering a new option for those with long-term knee pain.
This trial tests if a new medicine, NNC0487-0111, can help people with excess weight and knee osteoarthritis lose weight and reduce knee pain. It is for people who have had knee pain for at least three months and who can stop taking pain relievers for short periods before study visits.
This trial tests whether Laybon Tab. helps reduce knee pain in people with knee osteoarthritis. It is for adults aged 40 to 80 who have had knee pain for at least 3 months and are ready to stop other pain treatments during the study.
Hear when a new Chronic pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.